- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
| home:tests:125d [12.31.2013] – [Test: 1,25-dihydroxvitamin D (1,25-D)] typo joyful | home:tests:125d [12.31.2013] – [Validity of the 1,25-D test and alternatives] additional information about testing changes joyful | ||
|---|---|---|---|
| Line 72: | Line 72: | ||
| Variability in levels of 1,25-D somewhat compromises the validity of a serum 1,25-D test as an absolute measure for disease state. For this reason, candidates for the MP are advised that the ultimate measure for suitability for the MP is the therapeutic probe. | Variability in levels of 1,25-D somewhat compromises the validity of a serum 1,25-D test as an absolute measure for disease state. For this reason, candidates for the MP are advised that the ultimate measure for suitability for the MP is the therapeutic probe. | ||
| + | |||
| + | In addition, since the introduction of the Marshall Protocol, the actual 1,25D test performed by laboratories has been modified and may not be picking up the same factors as were being detected in patients with Th1 illness by the prior testing method. | ||
home/tests/125d.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.